|
Market Closed -
Nasdaq
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 5.990 USD | +0.34% |
|
+1.01% | -43.97% |
| 08-27 | Outlook Therapeutics Appoints Kevin Lundquist as CFO | MT |
| 08-13 | CapsoVision, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 300M 258M 243M 222M 415M 28.3B 416M 2.87B 1.11B 14.52B 1.13B 1.1B 46.78B | P/E 2026 * |
-10.7x | P/E 2027 * | -13.6x |
|---|---|---|---|---|---|
| Enterprise Value | 300M 258M 243M 222M 415M 28.3B 416M 2.87B 1.11B 14.52B 1.13B 1.1B 46.78B | EV / Sales 2026 * |
20.2x | EV / Sales 2027 * | 15.1x |
| Free-Float |
67.96% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CV | Delayed | |
CBOE
| CV | Real-time | |
|
Deutsche Boerse AG
| H6U | Delayed |
Last Transcript : CapsoVision, Inc.
| 1 day | +0.34% | ||
| 1 week | +1.01% | ||
| Current month | +2.57% | ||
| 1 month | -11.52% | ||
| 3 months | -16.69% | ||
| 6 months | +18.38% | ||
| Current year | -43.97% |
| 1 week | 5.78 |  | 6.13 |
| 1 month | 5.75 | | 7.18 |
| Current year | 4.5 | | 11.37 |
| 1 year | 3.43 | | 15.37 |
| 3 years | 3.43 | | 15.37 |
| 5 years | 3.43 | | 15.37 |
| 10 years | 3.43 | | 15.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
CEO | Chief Executive Officer | 69 | 31/10/2024 |
David Garcia
DFI | Director of Finance/CFO | 52 | - |
Keri Jorgenson
PRN | Corporate Officer/Principal | - | 28/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
BRD | Director/Board Member | 69 | 31/10/2024 |
Chen Lung Tsai
CHM | Chairman | 74 | 31/12/2024 |
Hui Ying Kuo
BRD | Director/Board Member | 55 | 31/01/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/07/26 | Buy | Director | 61,068 | 0.1225% | ||
| 08/07/26 | Buy | Director | 81,300 | 0.1631% | ||
| 01/07/26 | Free | Director | 1,710 | 0.0034% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.34% | +1.01% | +67.32% | - | 300M | |
| +3.33% | +2.86% | -23.88% | +1.56% | 13.22B | |
| -2.36% | -4.13% | +10.60% | +8.67% | 4.23B | |
| +3.96% | +3.48% | -37.52% | -54.42% | 1.27B | |
| -1.36% | -1.81% | -36.41% | -40.71% | 1.14B | |
| -3.63% | -4.16% | +15.92% | +76.05% | 1.07B | |
| -1.80% | -0.34% | - | - | 1.03B | |
| -0.50% | -2.68% | -37.21% | - | 1.02B | |
| -3.35% | -6.37% | +25.67% | +100.16% | 503M | |
| -3.25% | -0.17% | -67.60% | +306.52% | 247M | |
| Average | -0.86% | -1.71% | -9.23% | +56.83% | 2.4B | |
| Weighted average by Cap. | +1.20% | +0.29% | -15.85% | +6.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.87M 12.8M 12.04M 11M 20.58M 1.4B 20.63M 142M 55.21M 720M 55.85M 54.63M 2.32B | 19.82M 17.06M 16.05M 14.66M 27.43M 1.87B 27.5M 190M 73.59M 960M 74.44M 72.81M 3.09B |
| Net income | -27.56M -23.71M -22.31M -20.38M -38.12M -2.6B -38.23M -264M -102M -1.33B -103M -101M -4.3B | -22.1M -19.02M -17.89M -16.34M -30.58M -2.09B -30.66M -211M -82.04M -1.07B -82.99M -81.18M -3.45B |
| Net Debt | - | - |
Employees
99
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$5.990 | +0.34% | 38,501 |
| 03/09/26 | US$5.970 | +0.67% | 62,720 |
| 02/09/26 | US$5.930 | +1.02% | 58,639 |
| 01/09/26 | US$5.870 | +0.51% | 62,215 |
| 31/08/26 | US$5.840 | -1.52% | 58,773 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.990USD
Average target price
9.500USD
Spread / Average Target
+58.60%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CV Stock
Select your edition
All financial news and data tailored to specific country editions
